The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic
Autoři | |
---|---|
Rok publikování | 2017 |
Druh | Konferenční abstrakty |
Fakulta / Pracoviště MU | |
Citace | |
Popis | Meeting abstract The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic. |